STERIS Receivables 2010-2025 | STE

STERIS receivables for the quarter ending March 31, 2025 were $1.044B, a 3.54% increase year-over-year.

  • STERIS receivables for 2025 were $1.044B, a 3.54% increase from 2024.
  • STERIS receivables for 2024 were $1.008B, a 16.57% increase from 2023.
  • STERIS receivables for 2023 were $0.865B, a 8.25% increase from 2022.

STERIS Receivables 2010-2025 | STE

  • STERIS receivables for 2025 were $1.044B, a 3.54% increase from 2024.
  • STERIS receivables for 2024 were $1.008B, a 16.57% increase from 2023.
  • STERIS receivables for 2023 were $0.865B, a 8.25% increase from 2022.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$188.5B
Thermo Fisher Scientific (TMO)$162.6B
Edwards Lifesciences (EW)$46.2B
Alcon (ALC)$43.8B
IDEXX Laboratories (IDXX)$43.5B
DexCom (DXCM)$33.5B
IQVIA Holdings (IQV)$28.6B
Mettler-Toledo (MTD)$25.7B
Waters (WAT)$21B
SONOVA HOLDING (SONVY)$17.7B
Hologic (HOLX)$14.9B
Sysmex ADR (SSMXY)$10.5B
Penumbra (PEN)$9.4B
Masimo (MASI)$9B
Globus Medical (GMED)$7.8B
Glaukos (GKOS)$6.1B
Teleflex (TFX)$5.3B
Integer Holdings (ITGR)$4.2B
TransMedics (TMDX)$4.2B
PROCEPT BioRobotics (PRCT)$3.3B
LivaNova (LIVN)$2.5B
Veracyte (VCYT)$2.2B
Nihon Kohden (NHNKY)$2.1B
Elekta AB (EKTAY)$2B
Alphatec Holdings (ATEC)$1.7B
Artivion (AORT)$1.4B
Pulse Biosciences (PLSE)$1.2B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Tandem Diabetes Care (TNDM)$1.1B